Healthcare Equipment and Supplies
Company Overview of OrthoAccel Technologies, Inc.
OrthoAccel Technologies, Inc., a medical device company, develops, manufactures, and markets products for dental care and orthodontic treatment. It offers AcceleDent Aura, a hands-free device that accelerates orthodontic tooth movement for orthodontic treatment. The company offers its products through orthodontic practices in the United States and internationally. OrthoAccel Technologies, Inc. was incorporated in 2006 and is based in Bellaire, Texas.
6575 West Loop South
Bellaire, TX 77401
Founded in 2006
Key Executives for OrthoAccel Technologies, Inc.
Chief Executive Officer, President and Director
Chief Financial Officer and Vice President of Finance and Administration
Chief Innovation Officer and Vice President of Marketing
Managing Director for Europe, Middle East and Africa (EMEA)
Compensation as of Fiscal Year 2015.
OrthoAccel Technologies, Inc. Key Developments
OrthoAccel Announces Publication of Randomized Controlled Trial Results
Sep 9 15
OrthoAccel announced publication of randomized controlled trial results. The trial, which was conducted at the University of Texas Health Science Center at San Antonio, assessed 45 orthodontic patients who were randomized into two groups the AcceleDent group and a control group. Patients in the AcceleDent group were given the hands-free device that employs patented SoftPulse Technology® and were instructed to bite down on the device's mouthpiece for 20 minutes a day. AcceleDent delivered the safe, gentle vibrations needed to stimulate tooth movement at the cellular level. Results indicated that the rate of movement was significantly higher for the AcceleDent group versus the control group. An FDA-cleared, Class II medical device, AcceleDent speeds up orthodontic treatment by as much as 50% and orthodontists as well as patients report that AcceleDent relieves the discomfort often associated with orthodontics. AcceleDent is currently available in more than 2,700 orthodontic locations in the U.S. and Canada. The results of this RCT have been applauded by distinguished clinical researchers and scientists.
OrthoAccel Technologies, Inc. Appoints Frank Grunau as Regional Director for Europe, Middle East and Africa
Sep 2 15
OrthoAccel Technologies, Inc. announced that Frank Grunau has joined the company as regional director for Europe, Middle East and Africa (EMEA). As the newly appointed EMEA regional director, Grunau will serve as a key member of the executive leadership team and will lead an aggressive EU growth strategy for AcceleDent.
Len Hedge Joins OrthoAccel's Board of Directors
May 12 15
OrthoAccel Technologies, Inc. announced that Len Hedge, a retired Align Technology senior executive, has joined OrthoAccel's board of directors. The leader in accelerated orthodontics, OrthoAccel develops and manufactures AcceleDent®, the first and only FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50%. Hedge currently serves on the boards of directors for two additional dental companies, Convergent Dental, Inc. and MicroDental Laboratories.
Similar Private Companies By Industry
Recent Private Companies Transactions
November 10, 2014